Company intelligence / Profile preview

Shanghai Clinical Research Center

Shanghai, Shanghai, China

Ownership: Private
Development stage: Other

Overview

SCRC operates as a leading third-party full-service clinical research center in China with expertise in Phase I clinical trials, bioequivalence studies, and clinical pharmacology studies since 1999[4]. The organization provides comprehensive drug development services including central laboratory capabilities, data management, and biostatistics[1].

Industry: Contract Research Organization

Partnerships

Ministry of Science and TechnologyShanghai Municipalitypharmaceutical companieshospital network throughout China

Beyond the preview

Go deeper on Shanghai Clinical Research Center.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shanghai Clinical Research Center.

Explore the full profile